Darifenacin and Itching - a phase IV clinical study of FDA data

Summary:

Itching is reported as a side effect among people who take Darifenacin (darifenacin hydrobromide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Humira, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Itching when taking Darifenacin. It is created by eHealthMe based on reports of 1,258 people who have side effects when taking Darifenacin from the FDA, and is updated regularly.

What is Darifenacin?

Darifenacin has active ingredients of darifenacin hydrobromide. eHealthMe is studying from 1,259 Darifenacin users. Check the latest studies of Darifenacin.

What is Itching?

Itching is found to be associated with 3,211 drugs and 4,535 conditions by eHealthMe. Check the latest studies of Itching.

On Jul, 10, 2026

1,258 people reported to have side effects when taking Darifenacin.
Among them, 35 people (2.78%) have Itching.

Among these 35 people:

How long have people been on Darifenacin when they have Itching? *

What is the gender of people who have Itching when taking Darifenacin? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Itching when taking Darifenacin? *

What are other drugs people take besides Darifenacin? *

What are other side effects people have besides Itching? *

Headache (pain in head): 20 people, 57.14%
Rashes (redness): 19 people, 54.29%
Fatigue (feeling of tiredness): 17 people, 48.57%
Nausea (feeling of having an urge to vomit): 16 people, 45.71%
Weakness: 14 people, 40.00%
Drug Ineffective: 14 people, 40.00%
Joint Pain: 14 people, 40.00%
Drug Intolerance (drug sensitivity): 14 people, 40.00%
Back Pain: 13 people, 37.14%
Pain: 13 people, 37.14%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 11 people, 31.43%
Pain: 8 people, 22.86%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 22.86%
Joint Pain: 7 people, 20.00%
Depression: 5 people, 14.29%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 5 people, 14.29%
Constipation: 5 people, 14.29%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 5 people, 14.29%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 14.29%
Sinusitis (inflammation of sinus): 5 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Darifenacin and have Itching?

- Check whether Itching is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Darifenacin:

Darifenacin (1,259 reports)

Itching treatments and more:

Itching (398,821 reports)

Browse all side effects of Darifenacin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Itching:

Itching (3,211 drugs)

Browse all the conditions that are associated with Itching:

Itching (4,535 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on darifenacin hydrobromide (the active ingredients of Darifenacin) and Darifenacin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.